{"transactions":[{"id":4171396,"issuer":{"id":130904,"kind":"organization","name":"Allena Pharmaceuticals, Inc.","symbol":"ALNA"},"owners":[{"id":161859,"kind":"organization","name":"FHM VI, L.L.C.","position":1,"cik":"0001456654","reported_name":"FHM VI, L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":161860,"kind":"organization","name":"FHM VI, L.P.","position":2,"cik":"0001456655","reported_name":"FHM VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":161861,"kind":"organization","name":"Frazier Healthcare VI, L.P.","position":3,"cik":"0001456656","reported_name":"Frazier Healthcare VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series C Preferred Stock","published_at":"2017-11-06T18:46:53.000Z","date":"2017-11-06","kind":"exercise","acquired":false,"shares":1061904,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Frazier Healthcare VI, L.P."},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"The Series C Preferred Stock automatically converted into Common Stock of the Issuer on a 4.174-to-1 basis upon closing of the initial public offering of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The Series C Preferred Stock automatically converted into Common Stock of the Issuer on a 4.174-to-1 basis upon closing of the initial public offering of the Issuer."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Not applicable."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The securities are held by Frazier Healthcare VI, L.P. (\"Frazier VI\"). FHM VI, L.P. (\"FHM LP\") is the general partner of Frazier VI and FHM VI, L.L.C. (\"FHM LLC\") is the general partner of FHM LP. Each of FHM LLC and FHM LP disclaims beneficial ownership of all shares held by Frazier VI except to the extent, if any, of such entity's, as applicable, pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":254409},"source":{"system":"sec-edgar","filing":"0001209191-17-059504","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1624658/000120919117059504/doc4.xml","form_type":"4"}},{"id":4171395,"issuer":{"id":130904,"kind":"organization","name":"Allena Pharmaceuticals, Inc.","symbol":"ALNA"},"owners":[{"id":161859,"kind":"organization","name":"FHM VI, L.L.C.","position":1,"cik":"0001456654","reported_name":"FHM VI, L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":161860,"kind":"organization","name":"FHM VI, L.P.","position":2,"cik":"0001456655","reported_name":"FHM VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":161861,"kind":"organization","name":"Frazier Healthcare VI, L.P.","position":3,"cik":"0001456656","reported_name":"Frazier Healthcare VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B Preferred Stock","published_at":"2017-11-06T18:46:53.000Z","date":"2017-11-06","kind":"exercise","acquired":false,"shares":4629630,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Frazier Healthcare VI, L.P."},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The Series B Preferred Stock automatically converted into Common Stock of the Issuer on a 4.174-to-1 basis upon closing of the initial public offering of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Series B Preferred Stock automatically converted into Common Stock of the Issuer on a 4.174-to-1 basis upon closing of the initial public offering of the Issuer."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Not applicable."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The securities are held by Frazier Healthcare VI, L.P. (\"Frazier VI\"). FHM VI, L.P. (\"FHM LP\") is the general partner of Frazier VI and FHM VI, L.L.C. (\"FHM LLC\") is the general partner of FHM LP. Each of FHM LLC and FHM LP disclaims beneficial ownership of all shares held by Frazier VI except to the extent, if any, of such entity's, as applicable, pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1109159},"source":{"system":"sec-edgar","filing":"0001209191-17-059504","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1624658/000120919117059504/doc4.xml","form_type":"4"}},{"id":4171394,"issuer":{"id":130904,"kind":"organization","name":"Allena Pharmaceuticals, Inc.","symbol":"ALNA"},"owners":[{"id":161859,"kind":"organization","name":"FHM VI, L.L.C.","position":1,"cik":"0001456654","reported_name":"FHM VI, L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":161860,"kind":"organization","name":"FHM VI, L.P.","position":2,"cik":"0001456655","reported_name":"FHM VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":161861,"kind":"organization","name":"Frazier Healthcare VI, L.P.","position":3,"cik":"0001456656","reported_name":"Frazier Healthcare VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A Preferred Stock","published_at":"2017-11-06T18:46:53.000Z","date":"2017-11-06","kind":"exercise","acquired":false,"shares":6122448,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Frazier Healthcare VI, L.P."},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Series A Preferred Stock automatically converted into Common Stock of the Issuer on a 4.174-to-1 basis upon closing of the initial public offering of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Series A Preferred Stock automatically converted into Common Stock of the Issuer on a 4.174-to-1 basis upon closing of the initial public offering of the Issuer."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Not applicable."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The securities are held by Frazier Healthcare VI, L.P. (\"Frazier VI\"). FHM VI, L.P. (\"FHM LP\") is the general partner of Frazier VI and FHM VI, L.L.C. (\"FHM LLC\") is the general partner of FHM LP. Each of FHM LLC and FHM LP disclaims beneficial ownership of all shares held by Frazier VI except to the extent, if any, of such entity's, as applicable, pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1466805},"source":{"system":"sec-edgar","filing":"0001209191-17-059504","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1624658/000120919117059504/doc4.xml","form_type":"4"}},{"id":4171393,"issuer":{"id":130904,"kind":"organization","name":"Allena Pharmaceuticals, Inc.","symbol":"ALNA"},"owners":[{"id":161859,"kind":"organization","name":"FHM VI, L.L.C.","position":1,"cik":"0001456654","reported_name":"FHM VI, L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":161860,"kind":"organization","name":"FHM VI, L.P.","position":2,"cik":"0001456655","reported_name":"FHM VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":161861,"kind":"organization","name":"Frazier Healthcare VI, L.P.","position":3,"cik":"0001456656","reported_name":"Frazier Healthcare VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-11-06T18:46:53.000Z","date":"2017-11-06","kind":"purchase","acquired":true,"shares":500000,"price":14,"value":7000000.0,"ownership":{"direct":false,"nature":"By Frazier Healthcare VI, L.P."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The securities are held by Frazier Healthcare VI, L.P. (\"Frazier VI\"). FHM VI, L.P. (\"FHM LP\") is the general partner of Frazier VI and FHM VI, L.L.C. (\"FHM LLC\") is the general partner of FHM LP. Each of FHM LLC and FHM LP disclaims beneficial ownership of all shares held by Frazier VI except to the extent, if any, of such entity's, as applicable, pecuniary interest therein."}],"balance_after":3330373,"source":{"system":"sec-edgar","filing":"0001209191-17-059504","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1624658/000120919117059504/doc4.xml","form_type":"4"}},{"id":4171392,"issuer":{"id":130904,"kind":"organization","name":"Allena Pharmaceuticals, Inc.","symbol":"ALNA"},"owners":[{"id":161859,"kind":"organization","name":"FHM VI, L.L.C.","position":1,"cik":"0001456654","reported_name":"FHM VI, L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":161860,"kind":"organization","name":"FHM VI, L.P.","position":2,"cik":"0001456655","reported_name":"FHM VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":161861,"kind":"organization","name":"Frazier Healthcare VI, L.P.","position":3,"cik":"0001456656","reported_name":"Frazier Healthcare VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-11-06T18:46:53.000Z","date":"2017-11-06","kind":"exercise","acquired":true,"shares":2830373,"ownership":{"direct":false,"nature":"By Frazier Healthcare VI, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Series A Preferred Stock automatically converted into Common Stock of the Issuer on a 4.174-to-1 basis upon closing of the initial public offering of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Series B Preferred Stock automatically converted into Common Stock of the Issuer on a 4.174-to-1 basis upon closing of the initial public offering of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The Series C Preferred Stock automatically converted into Common Stock of the Issuer on a 4.174-to-1 basis upon closing of the initial public offering of the Issuer."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The securities are held by Frazier Healthcare VI, L.P. (\"Frazier VI\"). FHM VI, L.P. (\"FHM LP\") is the general partner of Frazier VI and FHM VI, L.L.C. (\"FHM LLC\") is the general partner of FHM LP. Each of FHM LLC and FHM LP disclaims beneficial ownership of all shares held by Frazier VI except to the extent, if any, of such entity's, as applicable, pecuniary interest therein."}],"balance_after":2830373,"source":{"system":"sec-edgar","filing":"0001209191-17-059504","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1624658/000120919117059504/doc4.xml","form_type":"4"}}]}